Olympus (TSE:7733) - Stock Price, News & Analysis

7733 Stock Overview

Olympus Corporation manufactures and sells precision machineries and instruments worldwide.

7733 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 6.62% per year

Risk Analysis

Profit margins (6.3%) are lower than last year (13.7%)

Olympus Corporation Competitors

Terumo

TSE:4543

JP¥3.5t

Sysmex

TSE:6869

JP¥1.7t

Nihon Kohden

TSE:6849

JP¥312.4b

JEOL

TSE:6951

JP¥299.5b

Price History & Performance

Summary of all time highs, changes and price drops for Olympus
Historical stock prices
Current Share Price	JP¥2,193.00
52 Week High	JP¥2,729.00
52 Week Low	JP¥1,782.00
Beta	0.69
1 Month Change	7.42%
3 Month Change	9.51%
1 Year Change	-18.72%
3 Year Change	-7.39%
5 Year Change	177.59%
Change since IPO	554.63%

Recent updates

Shareholder Returns

	7733	JP Medical Equipment	JP Market
7D	-1.5%	0.5%	-0.01%
1Y	-18.7%	4.2%	18.2%

Return vs Industry: 7733 underperformed the JP Medical Equipment industry which returned 4.2% over the past year.

Return vs Market: 7733 underperformed the JP Market which returned 18.2% over the past year.

Price Volatility

Is 7733's price volatile compared to industry and market?
7733 volatility
7733 Average Weekly Movement	3.2%
Medical Equipment Industry Average Movement	3.5%
Market Average Movement	4.0%
10% most volatile stocks in JP Market	7.5%
10% least volatile stocks in JP Market	2.1%

Stable Share Price: 7733 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 7733's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1919	32,844	Stefan Kaufmann	https://www.olympus-global.com

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services.

Olympus Corporation Fundamentals Summary

How do Olympus's earnings and revenue compare to its market cap?
7733 fundamental statistics
Market Cap	JP¥2.61t
Earnings (TTM)	JP¥56.53b
Revenue (TTM)	JP¥901.51b

46.7x

P/E Ratio

2.9x

P/S Ratio

Is 7733 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
7733 income statement (TTM)
Revenue	JP¥901.51b
Cost of Revenue	JP¥293.75b
Gross Profit	JP¥607.76b
Other Expenses	JP¥551.23b
Earnings	JP¥56.53b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Feb 14, 2024

Earnings per share (EPS)	46.99
Gross Margin	67.42%
Net Profit Margin	6.27%
Debt/Equity Ratio	42.1%

How did 7733 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

35%

Payout Ratio

Does 7733 pay a reliable dividends?

See 7733 dividend history and benchmarks

When do you need to buy 7733 by to receive an upcoming dividend?
Olympus dividend dates
Ex Dividend Date	Mar 28 2024
Dividend Pay Date	Jun 06 2024
Days until Ex dividend	117 days
Days until Dividend pay date	187 days

Does 7733 pay a reliable dividends?

See 7733 dividend history and benchmarks

7733 Stock Overview

Rewards

Risk Analysis

Olympus Corporation Competitors

TSE:4543

JP¥3.5t

TSE:6869

JP¥1.7t

TSE:6849

JP¥312.4b

TSE:6951

JP¥299.5b

Price History & Performance

Recent News & Updates

Olympus Corporation Announces Study Results Show the S Sustained Clinical Benefits of Spiration Valve System At 24 Months

Olympus Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Olympus Corporation (TSE:7733) announces an Equity Buyback for 53,000,000 shares, representing 4.34% for ¥80,000 million.

Olympus Corporation Announces Market Launch of EVIS X1 Endoscopy System

Olympus Corporation Announces the Launch of the Vathin E-SteriScope

Investor sentiment deteriorates as stock falls 16%

Recent updates

Olympus Corporation Announces Study Results Show the S Sustained Clinical Benefits of Spiration Valve System At 24 Months

Olympus Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Olympus Corporation (TSE:7733) announces an Equity Buyback for 53,000,000 shares, representing 4.34% for ¥80,000 million.

Olympus Corporation Announces Market Launch of EVIS X1 Endoscopy System

Olympus Corporation Announces the Launch of the Vathin E-SteriScope

Investor sentiment deteriorates as stock falls 16%

New minor risk - Share price stability

First quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Olympus Corporation Announces Publication of Study Data Demonstrating That the Minimally Invasive Itind™? Treatment Provides Long-Lasting Relief of More Than Four Years

Olympus Corporation to Report Q3, 2024 Results on Feb 14, 2024

Full year 2023 earnings: EPS misses analyst expectations

Olympus Corporation Reiterates Consolidated Financial Guidance for the Fiscal Year Ending March 2024

Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

Full year 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 38%

Olympus Corporation, Annual General Meeting, Jun 27, 2023

Now 21% undervalued after recent price drop

Olympus Corporation Set to Demonstrate Newest Endoscopy System At DDW

Now 21% undervalued

Consensus EPS estimates increase by 79%

Consensus EPS estimates fall by 61%

Upcoming dividend of JP¥16.00 per share at 0.7% yield

Third quarter 2023 earnings released: EPS: JP¥28.43 (vs JP¥19.66 in 3Q 2022)

Olympus Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Consensus forecasts updated

Consensus forecasts updated

Second quarter 2023 earnings released

Second quarter 2023 earnings released

Olympus Corporation (TSE:7733) announces an Equity Buyback for 21,000,000 shares, representing 1.65% for ¥50,000 million.

Olympus Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Olympus Launches VISERA ELITE III Surgical Visualization Platform

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Bain Capital Private Equity, LP entered into a definitive agreement to acquire Scientific Solutions Business of Olympus Corporation from Olympus Corporation (TSE:7733) for approximately JPY 427.67 billion.

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Olympus Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

High number of new directors

Olympus Announces the Availability of New Monitor Option, the OEV321UH Video Display Monitor

Full year 2022 earnings: Revenues in line with analyst expectations

Olympus Corporation Announces Study Results Show Long-Term Efficacy of Itind Procedure

Investor sentiment improved over the past week

Olympus Corporation to Report Q3, 2023 Results on Feb 10, 2023

Full year 2022 earnings: EPS exceeds analyst expectations

Olympus Corporation Announces Dividend for the Year Ended March 31, 2022, Payable on June 3, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

High number of new directors

Olympus Corporation to Report Fiscal Year 2022 Results on May 11, 2022

Upcoming dividend of JP¥14.00 per share

Now 21% undervalued after recent price drop

Olympus Announces FDA Clearance of the Celeris Single-Use Sinus Debrider

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Olympus Corporation Proposes Board Resignations

Olympus Corporation Revises Consolidated Financial Guidance for the Fiscal Year Ending March 31, 2022

Olympus Corporation (TSE:7733) announces an Equity Buyback for 16,000,000 shares, representing 1.24% for ¥30,000 million.

Second quarter 2022 earnings released: EPS JP¥34.00 (vs JP¥20.25 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥14.54 (vs JP¥0.14 loss in 1Q 2021)

Full year 2021 earnings released: EPS JP¥51.03 (vs JP¥39.37 in FY 2020)

Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022

Accenture Japan Ltd entered into a definitive agreement to acquire Olympus Systems Corporation from Olympus Corporation (TSE:7733).